133 related articles for article (PubMed ID: 30732964)
1. Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma.
Kim YN; Kim M; Ahn HS; Kim K; Park SY; Kim HI; Jeon MJ; Kim WG; Kim SW; Kim WB; Chung JH; Shong YK; Kim TY; Kim TH
Oral Oncol; 2019 Feb; 89():8-13. PubMed ID: 30732964
[TBL] [Abstract][Full Text] [Related]
2. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
3. Modification of the Tumor-Node-Metastasis Staging System for Differentiated Thyroid Carcinoma by Considering Extra-Thyroidal Extension and Lateral Cervical Lymph Node Metastasis.
Kim M; Kim WG; Jeon MJ; Kim HK; Yi HS; Kim ES; Kim BH; Kim WB; Shong YK; Kang HC; Kim TY
Endocrinol Metab (Seoul); 2020 Mar; 35(1):149-156. PubMed ID: 32207275
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer.
Kim M; Kim WG; Oh HS; Park S; Kwon H; Song DE; Kim TY; Shong YK; Kim WB; Sung TY; Jeon MJ
Thyroid; 2017 Sep; 27(9):1149-1155. PubMed ID: 28635571
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer.
Kim M; Jeon MJ; Oh HS; Park S; Song DE; Sung TY; Kim TY; Chung KW; Kim WB; Shong YK; Lee YM; Kim WG
Thyroid; 2018 Apr; 28(4):496-503. PubMed ID: 29620964
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma.
Kim TH; Kim YN; Kim HI; Park SY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Kim K; Jeong JG; Kim SW; Chung JH
Oral Oncol; 2017 Aug; 71():81-86. PubMed ID: 28688696
[TBL] [Abstract][Full Text] [Related]
7. Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma.
Park SY; Cho YY; Kim HI; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Kim K; Kim SW; Chung JH; Kim TH
J Clin Endocrinol Metab; 2018 Dec; 103(12):4609-4616. PubMed ID: 30137493
[TBL] [Abstract][Full Text] [Related]
8. Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study.
Shteinshnaider M; Muallem Kalmovich L; Koren S; Or K; Cantrell D; Benbassat C
Thyroid; 2018 Feb; 28(2):201-209. PubMed ID: 29256827
[TBL] [Abstract][Full Text] [Related]
9. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG
Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
[TBL] [Abstract][Full Text] [Related]
10. Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?
Kim M; Kim YN; Kim WG; Park S; Kwon H; Jeon MJ; Ahn HS; Jung SH; Kim SW; Kim WB; Chung JH; Shong YK; Kim TH; Kim TY
Clin Endocrinol (Oxf); 2017 Mar; 86(3):438-443. PubMed ID: 27731521
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
[TBL] [Abstract][Full Text] [Related]
12. Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
Adam MA; Thomas S; Roman SA; Hyslop T; Sosa JA
JAMA Surg; 2017 Sep; 152(9):869-876. PubMed ID: 28636692
[TBL] [Abstract][Full Text] [Related]
13. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
[TBL] [Abstract][Full Text] [Related]
14. Impact of the updated TNM staging criteria on prediction of persistent disease in a differentiated thyroid carcinoma cohort.
Nava CF; Zanella AB; Scheffel RS; Maia AL; Dora JM
Arch Endocrinol Metab; 2019 Feb; 63(1):5-11. PubMed ID: 30864625
[TBL] [Abstract][Full Text] [Related]
15. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
[No Abstract] [Full Text] [Related]
16. Development and validation of a new staging system for node-negative gastric cancer based on recursive partitioning analysis: An international multi-institutional study.
Lin JX; Wang ZK; Wang W; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Zhou ZW; Huang CM
Cancer Med; 2019 Jun; 8(6):2962-2970. PubMed ID: 31070023
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the predicted impact of changes to the AJCC/TMN staging system for differentiated thyroid cancer (DTC): A prospective observational study of patients in South East Scotland.
Hulse K; Williamson A; Gibb FW; Conn B; Nixon IJ
Clin Otolaryngol; 2019 May; 44(3):330-335. PubMed ID: 30720920
[TBL] [Abstract][Full Text] [Related]
18. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
19. How Does The AJCC/TNM Staging System Eighth Edition Perform in Thyroid Cancer at A Major Middle Eastern Medical Center?
Alzahrani AS; Albalawi L; Mazi S; Mukhtar N; Aljamei H; Moria Y; Elsayed T; Amer L; Alanazi F; Alnasser L; Alqarni B; Fadel R; AlMatar A; Alqahtani A; Tuttle RM
Endocr Pract; 2021 Jun; 27(6):607-613. PubMed ID: 34120701
[TBL] [Abstract][Full Text] [Related]
20. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
